Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
Press release Ahead of World TB Day, Unitaid and FIND welcome WHO resources to accelerate access to faster, more accurate tests for drug-resistant tuberculosis.
DxConnect test directory Searchable directory of diagnostic tests for various diseases under the DxConnect umbrella.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Decentralizing manufacturing increases equitable access to testing We are supporting efforts to decentralize manufacturing so that every country has sustainable access to appropriate, affordable diagnostic tests.
Artificial intelligence has the potential to transform diagnosis Recent advancements in the use of AI range from tools that can help individuals self-triage, to tools focusing on improved healthcare provider capacity and decision making, and those aimed at improving efficiency of programmatic interventions.
Molecular testing can now be made available at the point of care A new generation of affordable, highly portable devices could enable molecular and multi-disease testing in primary care – essential for both for disease surveillance and patient care.
Lessons from innovations and positive outliers in diagnostic service delivery can be leveraged to inform policy and practice Experts, funders, and partners are coming together to identify innovations and country-level diagnostic programmes that are contributing to closing the gap in delivering diagnostic services.
DEC commitment to support implementation of the World Health Assembly Resolution on diagnostics The Diagnostics Equity Consortium (DEC) is a partnership between the Pan-African Treatment Access Movement (PATAM) and the Center for Global Health Policy & Politics at Georgetown University’s O’Neill Institute. DEC strives to ensure sustained political and programmatic commitment to affordable, suitable, effective, and accessible diagnostics.
